Home > About Us
Who We Are
Compass Bioinformatics is committed to becoming a global leader in Software as a Medical Device (SaMD) for multi-omics. We are a team of clinicians, AI data scientists, bioinformatics experts, and system developers across USA, Japan, and Taiwan.
On the path to conquering rare disorder diagnoses.
Since the first case in 2019 when the Compass solution was used to uncover a child’s condition - Alstrom Syndrome - we have helped over 3500 other patients in the last of 5 years.
There are 300 million patients with rare disorders across the world and each year 7 million new patients are affected.
Each instance of identifying the one true variant in three billion consumes the time, expertise, and care of overly taxed medical experts, which can lead to delays and misdiagnoses
Mission
The mission of Compass Bioinformatics is to usher in the era of personal genomics by making genomics analyses accessible, efficient, and inexpensive with the most sophisticated artificial intelligence algorithms.
At Compass Bioinformatics Inc., we are pioneering comprehensive human genome sequencing to learn more about the underlying causes of disease and laying the framework for AI-driven genetic analysis for all future generations.
We can create a healthier, more informed world for all of us with the help of InheriNext® user-friendly, efficient software.
Our Team
Leadership Team
Our team consists of medical & technological professionals & top-tier industry experts. Together, we bring decades of experience, innovation, and strategies to guide our mission. Our diverse backgrounds ensure we remain at the forefront of precision medicine, driving innovation and delivering high-quality solutions.
VP of Business Development
Chief Executive Officer
VP of Revenue & Product Innovation
Scientific Advisory Board
Compass Bioinformatics drives innovation with expert insights from our advisors, ensuring alignment with industry best practices, emerging trends, and regulatory standards.
Compass In Action
Compass Bioinformatics
- 4 mins
This week, Compass Bioinformatics announced that BRIM Biotechnology (TWSE:6885) will acquire a 42% stake in the company through a strategic investment of up to NT$150...
Compass Bioinformatics
- 2 mins
“As the 20th anniversary of whole genome sequencing (WGS) via next-generation sequencing (NGS) approaches, it seems appropriate to review the bioinformatics challenges addressed, and those...
Compass Bioinformatics
- 2 mins
A partnership that goes beyond innovation: It’s a promise to patients, families, and healthcare providers that the future of rare disease management will be precise,...